Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Another milestone in childhood spinal muscular atrophy.

Wokke JH.

Lancet Neurol. 2017 Jul;16(7):491-492. doi: 10.1016/S1474-4422(17)30121-7. Epub 2017 Apr 28. No abstract available.

PMID:
28460890
2.

[Increased CK activity in serum without symptoms: further investigations often unnecessary].

Voermans NC, de Visser M, Wokke JH, Brusse E.

Ned Tijdschr Geneeskd. 2013;157(41):A6315. Review. Dutch.

PMID:
24103135
3.

Long-term follow-up study on patients with Miyoshi phenotype of distal muscular dystrophy.

Linssen WH, de Voogt WG, Krahn M, Bernard R, Levy N, Wokke JH, Ginjaar HB, de Visser M.

Eur J Neurol. 2013 Jun;20(6):968-74. doi: 10.1111/ene.12129. Epub 2013 Mar 26.

PMID:
23530687
4.

Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic Process.

Langereis EJ, van den Berg IET, Halley DJJ, Poorthuis BJHM, Vaz FM, Wokke JHJ, Linthorst GE.

JIMD Rep. 2013;9:117-120. doi: 10.1007/8904_2012_189. Epub 2012 Oct 30.

5.

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.

Beauverd M, Mitchell JD, Wokke JH, Borasio GD.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002064. doi: 10.1002/14651858.CD002064.pub3. Review.

PMID:
23152212
6.

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study.

van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber KG, Verschuuren JJ, Reuser AJ, van der Ploeg AT, van Doorn PA.

Orphanet J Rare Dis. 2012 Nov 12;7:88. doi: 10.1186/1750-1172-7-88.

7.

Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study.

de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber CG, Verschuuren JJ, Kruijshaar ME, Reuser AJ, van Doorn PA, van der Ploeg AT.

Orphanet J Rare Dis. 2012 Sep 26;7:73. doi: 10.1186/1750-1172-7-73.

8.

Drug treatment for spinal muscular atrophy types II and III.

Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006282. doi: 10.1002/14651858.CD006282.pub4. Review. Update in: Cochrane Database Syst Rev. 2020 Jan 6;1:CD006282.

PMID:
22513940
9.

Drug treatment for spinal muscular atrophy type I.

Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006281. doi: 10.1002/14651858.CD006281.pub4. Review. Update in: Cochrane Database Syst Rev. 2019 Dec 11;12:CD006281.

PMID:
22513939
10.

Drug treatment for spinal muscular atrophy types II and III.

Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006282. doi: 10.1002/14651858.CD006282.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006282.

PMID:
22161400
11.

Drug treatment for spinal muscular atrophy type I.

Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006281. doi: 10.1002/14651858.CD006281.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006281.

PMID:
22161399
12.

Teaching NeuroImages: MRI changes of ictal cortical edema and tumor progression in a patient with astrocytoma.

Bouvy WH, Leijten FS, Ramos L, Wokke JH.

Neurology. 2011 Aug 16;77(7):e40-1. doi: 10.1212/WNL.0b013e3182299dfa. No abstract available.

PMID:
21844520
13.

Is cold paresis related to axonal depolarization?

Franssen H, Gebbink TA, Wokke JH, van den Berg LH, van Schelven LJ.

J Peripher Nerv Syst. 2010 Sep;15(3):227-37. doi: 10.1111/j.1529-8027.2010.00275.x.

PMID:
21040145
14.

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.

Cats EA, van der Pol WL, Piepers S, Franssen H, Jacobs BC, van den Berg-Vos RM, Kuks JB, van Doorn PA, van Engelen BG, Verschuuren JJ, Wokke JH, Veldink JH, van den Berg LH.

Neurology. 2010 Aug 31;75(9):818-25. doi: 10.1212/WNL.0b013e3181f0738e.

PMID:
20805527
15.

Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations.

Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM.

J Neurol. 2011 Feb;258(2):218-22. doi: 10.1007/s00415-010-5721-2. Epub 2010 Aug 29.

16.

Cold paresis in multifocal motor neuropathy.

Straver DC, van Asseldonk JT, Notermans NC, Wokke JH, van den Berg LH, Franssen H.

J Neurol. 2011 Feb;258(2):212-7. doi: 10.1007/s00415-010-5712-3. Epub 2010 Aug 28.

17.

Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid.

Piepers S, Cobben JM, Sodaar P, Jansen MD, Wadman RI, Meester-Delver A, Poll-The BT, Lemmink HH, Wokke JH, van der Pol WL, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):850-2. doi: 10.1136/jnnp.2009.200253. Epub 2010 Jun 15.

PMID:
20551479
18.

Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.

Niks EH, Kuks JB, Wokke JH, Veldman H, Bakker E, Verschuuren JJ, Plomp JJ.

Muscle Nerve. 2010 Aug;42(2):283-8. doi: 10.1002/mus.21642.

PMID:
20544919
19.

Juvenile-onset Alpers syndrome: interpreting MRI findings.

Visser NA, Braun KP, van den Bergh WM, Leijten FS, Willems CR, Ramos L, van den Bosch BJ, Smeets HJ, Wokke JH.

Neurology. 2010 Apr 13;74(15):1231-3. doi: 10.1212/WNL.0b013e3181d90005. No abstract available.

PMID:
20385895
20.

FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands.

Groen EJ, van Es MA, van Vught PW, Spliet WG, van Engelen-Lee J, de Visser M, Wokke JH, Schelhaas HJ, Ophoff RA, Fumoto K, Pasterkamp RJ, Dooijes D, Cuppen E, Veldink JH, van den Berg LH.

Arch Neurol. 2010 Feb;67(2):224-30. doi: 10.1001/archneurol.2009.329.

PMID:
20142531
21.

Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.

Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC.

Neurology. 2010 Feb 2;74(5):406-12. doi: 10.1212/WNL.0b013e3181ccc6b9.

PMID:
20124206
22.

Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis.

Van Es MA, Van Vught PW, Veldink JH, Andersen PM, Birve A, Lemmens R, Cronin S, Van Der Kooi AJ, De Visser M, Schelhaas HJ, Hardiman O, Ragoussis I, Lambrechts D, Robberecht W, Wokke JH, Ophoff RA, Van Den Berg LH.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):441-7. doi: 10.3109/17482960802673042.

PMID:
19922138
23.

Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review.

Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, Wokke JH, van den Berg LH.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):302-9. doi: 10.3109/17482960802455416. Review.

PMID:
19922117
24.

What we truly know about occupation as a risk factor for ALS: a critical and systematic review.

Sutedja NA, Fischer K, Veldink JH, van der Heijden GJ, Kromhout H, Heederik D, Huisman MH, Wokke JJ, van den Berg LH.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):295-301. doi: 10.3109/17482960802430799. Review.

PMID:
19922116
25.

Trends and determinants of end-of-life practices in ALS in the Netherlands.

Maessen M, Veldink JH, Onwuteaka-Philipsen BD, de Vries JM, Wokke JH, van der Wal G, van den Berg LH.

Neurology. 2009 Sep 22;73(12):954-61. doi: 10.1212/WNL.0b013e3181b87983.

PMID:
19770471
26.

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis.

Piepers S, Veldink JH, de Jong SW, van der Tweel I, van der Pol WL, Uijtendaal EV, Schelhaas HJ, Scheffer H, de Visser M, de Jong JM, Wokke JH, Groeneveld GJ, van den Berg LH.

Ann Neurol. 2009 Aug;66(2):227-34. doi: 10.1002/ana.21620.

PMID:
19743466
27.

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.

van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, van der Kooi AJ, de Visser M, Dahlberg C, Estrada K, Rivadeneira F, Hofman A, Zwarts MJ, van Doormaal PT, Rujescu D, Strengman E, Giegling I, Muglia P, Tomik B, Slowik A, Uitterlinden AG, Hendrich C, Waibel S, Meyer T, Ludolph AC, Glass JD, Purcell S, Cichon S, Nöthen MM, Wichmann HE, Schreiber S, Vermeulen SH, Kiemeney LA, Wokke JH, Cronin S, McLaughlin RL, Hardiman O, Fumoto K, Pasterkamp RJ, Meininger V, Melki J, Leigh PN, Shaw CE, Landers JE, Al-Chalabi A, Brown RH Jr, Robberecht W, Andersen PM, Ophoff RA, van den Berg LH.

Nat Genet. 2009 Oct;41(10):1083-7. doi: 10.1038/ng.442. Epub 2009 Sep 6.

PMID:
19734901
28.

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients.

Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, Langfelder P, DeYoung J, Wokke JH, Veldink JH, van den Berg LH, Ophoff RA.

BMC Genomics. 2009 Aug 27;10:405. doi: 10.1186/1471-2164-10-405.

29.

Rituximab for polyneuropathy with IgM monoclonal gammopathy.

Niermeijer JM, Eurelings M, Lokhorst HL, van der Pol WL, Franssen H, Wokke JH, Notermans NC.

J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1036-9. doi: 10.1136/jnnp.2008.155325.

PMID:
19684235
30.

AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands.

Faber CG, Molenaar PC, Vles JS, Bonifati DM, Verschuuren JJ, van Doorn PA, Kuks JB, Wokke JH, Beeson D, De Baets M.

J Neurol. 2009 Oct;256(10):1719-23. doi: 10.1007/s00415-009-5190-7. Epub 2009 Jun 21.

31.

Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.

Piepers S, van der Pol WL, Brugman F, Wokke JH, van den Berg LH.

Neurology. 2009 Jun 9;72(23):2057-8; author reply 2058. doi: 10.1212/01.wnl.0000349698.94744.1e. No abstract available.

PMID:
19506238
32.

A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.

Van den Berg-Vos RM, Visser J, Kalmijn S, Fischer K, de Visser M, de Jong V, de Haan RJ, Franssen H, Wokke JH, Van den Berg LH.

Arch Neurol. 2009 Jun;66(6):751-7. doi: 10.1001/archneurol.2009.91.

PMID:
19506135
33.

Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.

Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, Shi L, Wills AM, Broom WJ, Ticozzi N, Silani V, Ozoguz A, Rodriguez-Leyva I, Veldink JH, Ivinson AJ, Saris CG, Hosler BA, Barnes-Nessa A, Couture N, Wokke JH, Kwiatkowski TJ Jr, Ophoff RA, Cronin S, Hardiman O, Diekstra FP, Leigh PN, Shaw CE, Simpson CL, Hansen VK, Powell JF, Corcia P, Salachas F, Heath S, Galan P, Georges F, Horvitz HR, Lathrop M, Purcell S, Al-Chalabi A, Brown RH Jr.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9004-9. doi: 10.1073/pnas.0812937106. Epub 2009 May 18.

34.

Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes.

Brugman F, Veldink JH, Franssen H, de Visser M, de Jong JM, Faber CG, Kremer BH, Schelhaas HJ, van Doorn PA, Verschuuren JJ, Bruyn RP, Kuks JB, Robberecht W, Wokke JH, van den Berg LH.

Arch Neurol. 2009 Apr;66(4):509-14. doi: 10.1001/archneurol.2009.19.

PMID:
19364936
35.

Entrapment in anti myelin-associated glycoprotein neuropathy.

Faber CG, Notermans NC, Wokke JH, Franssen H.

J Neurol. 2009 Apr;256(4):620-4. doi: 10.1007/s00415-009-0132-y. Epub 2009 Mar 18.

PMID:
19306083
36.

Seipin/BSCL2 mutation screening in sporadic adult-onset upper motor neuron syndromes.

Brugman F, Scheffer H, Schelhaas HJ, Nillesen WM, Wokke JH, van de Warrenburg BP, van den Berg LH.

J Neurol. 2009 May;256(5):824-6. doi: 10.1007/s00415-009-5009-6. Epub 2009 Mar 1. No abstract available.

PMID:
19252810
37.

[Neuropsychiatric disorders. Multidisciplinary diagnosis and treatment].

Luykx JJ, Wolters FJ, Vulink NC, van der Erf M, Wokke JH, Kahn RS.

Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):75-9. Dutch. No abstract available.

PMID:
19235342
38.

Drug treatment for spinal muscular atrophy types II and III.

Bosboom W, Vrancken AF, van den Berg LH, Wokke JH, Iannaccone ST.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006282. doi: 10.1002/14651858.CD006282.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD006282.

PMID:
19160275
39.

Drug treatment for spinal muscular atrophy type I.

Bosboom W, Vrancken AF, van den Berg LH, Wokke J, Iannaccone ST.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006281. doi: 10.1002/14651858.CD006281.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD006281.

PMID:
19160274
40.

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease.

Van der Beek NA, Hagemans ML, Reuser AJ, Hop WC, Van der Ploeg AT, Van Doorn PA, Wokke JH.

Neuromuscul Disord. 2009 Feb;19(2):113-7. doi: 10.1016/j.nmd.2008.11.007. Epub 2008 Dec 11.

PMID:
19084399
41.

Clinical features of late-onset Pompe disease: a prospective cohort study.

Wokke JH, Escolar DM, Pestronk A, Jaffe KM, Carter GT, van den Berg LH, Florence JM, Mayhew J, Skrinar A, Corzo D, Laforet P.

Muscle Nerve. 2008 Oct;38(4):1236-45. doi: 10.1002/mus.21025.

PMID:
18816591
42.

Chapter 12 Multifocal and other motor neuropathies.

Van Den Berg LH, Franssen H, Van Asseldonk JT, Van Den Berg-Vos RM, Wokke JH.

Handb Clin Neurol. 2007;82:229-45. doi: 10.1016/S0072-9752(07)80015-7. No abstract available.

PMID:
18808897
43.

Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes.

Brugman F, Scheffer H, Wokke JH, Nillesen WM, de Visser M, Aronica E, Veldink JH, van den Berg LH.

Neurology. 2008 Nov 4;71(19):1500-5. doi: 10.1212/01.wnl.0000319700.11606.21. Epub 2008 Sep 17.

PMID:
18799786
44.

The realistic yield of lower leg SNAP amplitudes and SRAR in the routine evaluation of chronic axonal polyneuropathies.

Vrancken AF, Notermans NC, Wokke JH, Franssen H.

J Neurol. 2008 Aug;255(8):1127-35. doi: 10.1007/s00415-008-0817-7. Epub 2008 Aug 24.

PMID:
18719962
45.

A natural history study of late onset spinal muscular atrophy types 3b and 4.

Piepers S, van den Berg LH, Brugman F, Scheffer H, Ruiterkamp-Versteeg M, van Engelen BG, Faber CG, de Visser M, van der Pol WL, Wokke JH.

J Neurol. 2008 Sep;255(9):1400-4. doi: 10.1007/s00415-008-0929-0. Epub 2008 Jun 30.

PMID:
18575920
46.

Interpretation of electrodiagnostic findings in sporadic progressive muscular atrophy.

Visser J, de Visser M, Van den Berg-Vos RM, Van den Berg LH, Wokke JH, de Jong JM, Franssen H.

J Neurol. 2008 Jun;255(6):903-9. doi: 10.1007/s00415-008-0813-y. Epub 2008 May 19.

PMID:
18484238
47.

Extension of the clinical spectrum of Danon disease.

van der Kooi AJ, van Langen IM, Aronica E, van Doorn PA, Wokke JH, Brusse E, Langerhorst CT, Bergin P, Dekker LR, dit Deprez RH, de Visser M.

Neurology. 2008 Apr 15;70(16):1358-9. doi: 10.1212/01.wnl.0000309219.61785.b3. No abstract available.

PMID:
18413590
48.

Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study.

Dierick I, Baets J, Irobi J, Jacobs A, De Vriendt E, Deconinck T, Merlini L, Van den Bergh P, Rasic VM, Robberecht W, Fischer D, Morales RJ, Mitrovic Z, Seeman P, Mazanec R, Kochanski A, Jordanova A, Auer-Grumbach M, Helderman-van den Enden AT, Wokke JH, Nelis E, De Jonghe P, Timmerman V.

Brain. 2008 May;131(Pt 5):1217-27. doi: 10.1093/brain/awn029. Epub 2008 Mar 5.

PMID:
18325928
49.

Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen.

Blauw HM, Veldink JH, van Es MA, van Vught PW, Saris CG, van der Zwaag B, Franke L, Burbach JP, Wokke JH, Ophoff RA, van den Berg LH.

Lancet Neurol. 2008 Apr;7(4):319-26. doi: 10.1016/S1474-4422(08)70048-6. Epub 2008 Mar 3.

PMID:
18313986
50.

Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis.

van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, Van den Bosch L, de Jong SW, de Jong V, Baas F, van't Slot R, Lemmens R, Schelhaas HJ, Birve A, Sleegers K, Van Broeckhoven C, Schymick JC, Traynor BJ, Wokke JH, Wijmenga C, Robberecht W, Andersen PM, Veldink JH, Ophoff RA, van den Berg LH.

Nat Genet. 2008 Jan;40(1):29-31. Epub 2007 Dec 16.

PMID:
18084291

Supplemental Content

Support Center